| |
Centre for Policy on Ageing | |
 | |
|
| Outcome methodologies for pharmacologic trials in mild, moderate, and severe Alzheimer's disease | | Author(s) | Barry Reisberg, Alistair Burns, Serge Gauthier |
| Journal title | International Psychogeriatrics, vol 8, no 2, Summer 1996 |
| Pages | 344 pp |
| Keywords | Dementia ; Drugs ; Evaluation ; Clinical surveys ; Conference proceedings. |
| Annotation | Papers at a special meeting of the International Psychogeriatric Association (IPA) held under the auspices of the IPA's Pharmacy and Therapeutics Committee at New York University Medical Center in July 1994 are presented. The meeting's purpose was to bring together leading scientists, clinicians, and regulatory personnel to consider issues surrounding assessment of treatment efficacy in Alzheimer's disease (AD). In the last 10 to 15 years, there have been numerous trials of putative therapeutic agents in AD, virtually all of which have focused on remediation of cognitive deficits in a very restricted mild to moderate range of severity in AD. Since the late 1980s, behavioural disturbances in AD have become more prevalent. Consequently, new assessment measures are required for negativity, agitation, and refusal to co-operate. This issue of International Psychogeriatrics presents state-of-the-art reviews of some widely used AD assessments, along with some new and less well-known assessment measures. (RH). |
| Accession Number | CPA-980303252 B |
| Classmark | EA: LLD: 4C: 3G: 6M |
Data © Centre for Policy on Ageing |
|
| ...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|